FDA Investigating Metformin for Possible Carcinogen – Medscape

0
450
FDA Investigating Metformin for Possible Carcinogen – Medscape

The Food and Drug Administration has begun testing samples of metformin for NDMA. The fourth most-prescribed drug in the US, metformin is generally the first medication prescribed for type 2 diabetes.
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here